Literature DB >> 20498528

X-ray computed tomography contrast agents prepared by seeded growth of gold nanoparticles in PEGylated dendrimer.

Chie Kojima1, Yasuhito Umeda, Mikako Ogawa, Atsushi Harada, Yasuhiro Magata, Kenji Kono.   

Abstract

Gold nanoparticles (Au NPs) are a potential x-ray computed tomography (CT) contrast agent. A biocompatible and bioinactive surface is necessary for application of gold nanoparticle to CT imaging. Polyethylene glycol (PEG)-attached dendrimers have been used as a drug carrier with long blood circulation. In this study, the Au NPs were grown in the PEGylated dendrimer to produce a CT contrast agent. The Au NPs were grown by adding gold ions and ascorbic acid at various equivalents to the Au NP-encapsulated dendrimer solution. Both size and surface plasmon absorption of the grown Au NPs increased with adding a large number of gold ions. The x-ray attenuation of the Au NPs also increased after the seeded growth. The Au NPs grown in the PEG-attached dendrimer at the maximum under our conditions exhibited a similar CT value to a commercial iodine agent, iopamidol, in vitro. The Au NP-loaded PEGylated dendrimer and iopamidol were injected into mice and CT images were obtained at different times. The Au NP-loaded PEGylated dendrimer achieved a blood pool imaging, which was greater than a commercial iodine agent. Even though iopamidol was excreted rapidly, the PEGylated dendrimer loading the grown Au NP was accumulated in the liver.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20498528     DOI: 10.1088/0957-4484/21/24/245104

Source DB:  PubMed          Journal:  Nanotechnology        ISSN: 0957-4484            Impact factor:   3.874


  16 in total

Review 1.  Nanotechnology for computed tomography: a real potential recently disclosed.

Authors:  Nicolas Anton; Thierry F Vandamme
Journal:  Pharm Res       Date:  2013-07-30       Impact factor: 4.200

2.  Biodegradable iodinated polydisulfides as contrast agents for CT angiography.

Authors:  Erlei Jin; Zheng-Rong Lu
Journal:  Biomaterials       Date:  2014-04-24       Impact factor: 12.479

3.  DNA damage enhancement from gold nanoparticles for clinical MV photon beams.

Authors:  Ross I Berbeco; Houari Korideck; Wilfred Ngwa; Rajiv Kumar; Janki Patel; Srinivas Sridhar; Sarah Johnson; Brendan D Price; Alec Kimmelman; G Mike Makrigiorgos
Journal:  Radiat Res       Date:  2012-11-13       Impact factor: 2.841

4.  Nanomaterials for X-ray imaging: gold nanoparticle enhancement of X-ray scatter imaging of hepatocellular carcinoma.

Authors:  Danielle Rand; Vivian Ortiz; Yanan Liu; Zoltan Derdak; Jack R Wands; Milan Tatíček; Christoph Rose-Petruck
Journal:  Nano Lett       Date:  2011-06-06       Impact factor: 11.189

5.  Synthesis of highly stable and biocompatible gold nanoparticles for use as a new X-ray contrast agent.

Authors:  Pooya Iranpour; Maral Ajamian; Afsaneh Safavi; Nasser Iranpoor; Abdolkarim Abbaspour; Sanaz Javanmardi
Journal:  J Mater Sci Mater Med       Date:  2018-04-18       Impact factor: 3.896

6.  Effect of computed tomography scanning parameters on gold nanoparticle and iodine contrast.

Authors:  Merav Weill Galper; May Tun Saung; Valentin Fuster; Ewald Roessl; Axel Thran; Roland Proksa; Zahi Adel Fayad; David Peter Cormode
Journal:  Invest Radiol       Date:  2012-08       Impact factor: 6.016

7.  Advanced targeted nanomedicine.

Authors:  Mohan C Pereira; Mohan C M Arachchige; Yana K Reshetnyak; Oleg A Andreev
Journal:  J Biotechnol       Date:  2015-01-20       Impact factor: 3.307

8.  Poly(iohexol) nanoparticles as contrast agents for in vivo X-ray computed tomography imaging.

Authors:  Qian Yin; Felix Y Yap; Lichen Yin; Liang Ma; Qin Zhou; Lawrence W Dobrucki; Timothy M Fan; Ron C Gaba; Jianjun Cheng
Journal:  J Am Chem Soc       Date:  2013-09-04       Impact factor: 15.419

Review 9.  Nanoparticle contrast agents for computed tomography: a focus on micelles.

Authors:  David P Cormode; Pratap C Naha; Zahi A Fayad
Journal:  Contrast Media Mol Imaging       Date:  2014 Jan-Feb       Impact factor: 3.161

10.  Dendrimer-based MRI contrast agents: the effects of PEGylation on relaxivity and pharmacokinetics.

Authors:  Chie Kojima; Baris Turkbey; Mikako Ogawa; Marcelino Bernardo; Celeste A S Regino; L Henry Bryant; Peter L Choyke; Kenji Kono; Hisataka Kobayashi
Journal:  Nanomedicine       Date:  2011-04-08       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.